A detailed history of North Crest Asset Manangement, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 2,500 shares of ABBV stock, worth $438,950. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,500
Previous 128,928 98.06%
Holding current value
$438,950
Previous $22.1 Million 97.77%
% of portfolio
0.02%
Previous 0.76%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $348,487 - $423,974
2,127 Added 1.65%
131,055 $25.9 Million
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $569,781 - $665,377
3,681 Added 2.94%
128,928 $22.1 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $18,539 - $21,123
-116 Reduced 0.09%
125,247 $22.8 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $160,579 - $180,849
-1,167 Reduced 0.92%
125,363 $19.4 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $16.8 Million - $19.4 Million
125,730 Added 15716.25%
126,530 $18.9 Million
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $106,008 - $131,920
800 New
800 $107,000
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $480,488 - $576,232
-3,474 Reduced 3.64%
92,036 $14.9 Million
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $96,362 - $110,521
718 Added 0.76%
95,510 $12.8 Million
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $52,708 - $67,009
383 Added 0.41%
94,792 $14.5 Million
Q1 2022

Apr 18, 2022

BUY
$131.98 - $163.75 $330,345 - $409,866
2,503 Added 2.72%
94,409 $15.3 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $9.87 Million - $12.5 Million
91,906 New
91,906 $12.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.